What are the chances Skubal gets traded? Execs around baseball weigh in

Tarik Skubal underwent elbow surgery on May 6 and is already back to a 40-pitch simulated game, but his future with the Tigers remains uncertain as Detroit sits 22-34 and 10 games back in the AL Central. Rival executives think a trade before the Aug. 3 deadline is possible if the club falls further out of contention, with the Dodgers, Braves and Brewers cited as logical landing spots. The article highlights his record $32 million 2026 salary and the likelihood Detroit could move him rather than risk losing him in free agency.

Analysis

This is less a baseball story than a real-options problem around a scarce asset with asymmetric timing. The surgery likely compressed Detroit’s negotiating window into a few weeks: every rehab outing that shows velocity and command restores optionality for contenders, but every team-loss simultaneously raises the probability that management monetizes the arm rather than the season. The market’s mistake will be treating the situation as binary; the more important signal is whether Detroit stays within a single hot streak of the Wild Card by mid-July, because that is the point where holding becomes rational even if a winter departure remains likely.

The second-order effect is on contender behavior, not just Detroit. A true front-line starter at deadline scale forces marginal bidders to clear a much higher bar, which can widen the gap between the Dodgers/Braves-style capital-rich buyers and everyone else. That tends to depress the rest of the SP market: if Skubal is available, mid-tier starters become relative substitutes and may actually cheapen in July as teams wait for the premium outcome or pivot to lower-cost depth.

The contrarian read is that the market may be overestimating trade probability and underestimating the signaling value of a competitive July. A club can rationally keep a star through the deadline if the rehab indicates immediate post-return impact, because two months of elite pitching can materially change playoff odds and protect future franchise value more than a prospect package that is unlikely to match the player’s top-decile outcome. The key catalyst is not rumor volume; it is the team’s record versus the final Wild Card line by the first week of July and whether Skubal’s stuff looks fully intact in his first 2-3 appearances back.

Key Decisions for Investors

• No direct equity expression exists here; use the situation as a catalyst template for MLB-adjacent media/sports-betting names only if there is demonstrated trading sensitivity to deadline volatility. Otherwise stay out.
• Trade the second-order winner/loser dynamic in the broader SP market: look to buy quality starting-pitching scarcity into mid-July on any team-level injury selloff, and fade any assumption that one marquee arm will absorb all demand.
• Set a calendar spread on trade-probability headlines: expect a modest volatility pickup around the first two rehab starts and again in the first week of July; fade overreaction until Detroit is clearly outside the Wild Card band.
• If forced to express a view, lean contrarian to the consensus trade narrative: wait for concrete competitive deterioration before assigning high probability to a deadline move, because the hold case remains viable if the team stabilizes for just 10-14 days.